XML 29 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 03, 2025
Jan. 21, 2025
Sep. 30, 2025
Jun. 30, 2025
Jan. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 26, 2025
May 07, 2025
Dec. 31, 2024
Dec. 31, 2023
Proceeds from issuance of stock               $ 8,640 $ 2,434        
Securities called by warrants                   1,500,000      
Exercise price (in dollars per share)                   $ 0.65 $ 0.65    
Agreement for net proceeds               27,200          
Issuance of common stock, net of issuance costs           $ 4,995 $ 599 [1] 7,495 $ 2,434 [2]        
Issuance of equity to settle the loan (shares) 14,204,846   14,204,846 14,204,846                  
Issuance of equity to settle the loan $ 6,400   $ 6,400 $ 6,400   $ 6,392   $ 6,392          
Maximum                          
Securities called by warrants                   1,500,000 1,500,000    
Performance share units                          
Number of nonvested shares held     761,066     761,066 1,328,922 761,066 1,328,922     1,328,922 880,926
Forfeited for net settlement (in shares)               (48,066)          
Deferred share units                          
Number of nonvested shares held     924,569     924,569 769,499 924,569 769,499     883,384 586,291
Forfeited for net settlement (in shares)               (27,267)          
Chief Operating Officer | Performance share units                          
Number of nonvested shares held     90,311     90,311   90,311          
Percentage of performance target measure (in percent)     100.00%     100.00%   100.00%          
Number of shares issued               42,265          
Forfeited for net settlement (in shares)               48,066          
Chief Operating Officer | Deferred share units                          
Number of nonvested shares held     51,242     51,242   51,242          
Number of shares issued               23,975          
Forfeited for net settlement (in shares)               27,267          
ATM Agreement                          
Common stock sold     25,315,954     0 1,230,180 25,139,655 4,708,993        
Proceeds from issuance of stock             $ 600 $ 8,600 $ 2,400        
Issuance of common stock, net of issuance costs             $ 600 $ 8,640 [2] $ 2,400        
Registered Direct Offering                          
Common stock sold   15,625,000     15,625,000                
Price per share (in dollars per share) $ 0.45 $ 0.16 $ 0.45   $ 0.16 $ 0.45   $ 0.45          
Proceeds from issuance of stock $ 11,400 $ 2,500 $ 11,400                    
Issuance of common stock, net of issuance costs     $ 11,400                    
[1] No shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2025. 1,230,180 shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2024, for net proceeds of approximately $0.6 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—16 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.
[2] An aggregate of 25,139,655 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2025, for proceeds of approximately $8.6 million to the Company, after deducting the agent’s commissions and other fees. 4,708,993 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2024, for proceeds of approximately $2.4 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—15 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.